These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17194724)

  • 41. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
    Perrin MH; Sutton S; Bain DL; Berggren WT; Vale WW
    Endocrinology; 1998 Feb; 139(2):566-70. PubMed ID: 9449626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The CRF(1) receptor antagonist, NBI-35965, abolished the activation of locus coeruleus neurons induced by colorectal distension and intracisternal CRF in rats.
    Kosoyan HP; Grigoriadis DE; Taché Y
    Brain Res; 2005 Sep; 1056(1):85-96. PubMed ID: 16095571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice.
    Moffatt JD; Lever R; Page CP
    FASEB J; 2006 Sep; 20(11):1877-9. PubMed ID: 16855006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
    Stiedl O; Meyer M; Jahn O; Ogren SO; Spiess J
    J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRF1 receptors as a therapeutic target for irritable bowel syndrome.
    Martinez V; Taché Y
    Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fecal pellet output does not always correlate with colonic transit in response to restraint stress and corticotropin-releasing factor in rats.
    Nakade Y; Mantyh C; Pappas TN; Takahashi T
    J Gastroenterol; 2007 Apr; 42(4):279-82. PubMed ID: 17464456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist.
    Valdez GR; Zorrilla EP; Rivier J; Vale WW; Koob GF
    Brain Res; 2003 Aug; 980(2):206-12. PubMed ID: 12867260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antagonism of specific corticotropin-releasing factor receptor subtypes selectively modifies weight loss in restrained rats.
    Chotiwat C; Harris RB
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1762-73. PubMed ID: 18922964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
    Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2.
    Radulovic J; Rühmann A; Liepold T; Spiess J
    J Neurosci; 1999 Jun; 19(12):5016-25. PubMed ID: 10366634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effect of Peripheral CRF Peptide and Water Avoidance Stress on Colonic and Gastric Transit in Guinea Pigs.
    Hussain Z; Kim HW; Huh CW; Lee YJ; Park H
    Yonsei Med J; 2017 Jul; 58(4):872-877. PubMed ID: 28541004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor.
    Campbell SN; Zhang C; Monte L; Roe AD; Rice KC; Taché Y; Masliah E; Rissman RA
    J Alzheimers Dis; 2015; 43(3):967-76. PubMed ID: 25125464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells.
    Gué M; Del Rio-Lacheze C; Eutamene H; Théodorou V; Fioramonti J; Buéno L
    Neurogastroenterol Motil; 1997 Dec; 9(4):271-9. PubMed ID: 9430796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.
    Stenzel-Poore MP; Heinrichs SC; Rivest S; Koob GF; Vale WW
    J Neurosci; 1994 May; 14(5 Pt 1):2579-84. PubMed ID: 8182429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The blockage of ventromedial hypothalamus CRF type 2 receptors impairs escape responses in the elevated T-maze.
    Silva MSCF; Souza TMO; Pereira BA; Ribeiro DA; Céspedes IC; Bittencourt JC; Viana MB
    Behav Brain Res; 2017 Jun; 329():41-50. PubMed ID: 28435125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.
    Yeh C; Ting CH; Doong ML; Chi CW; Lee SD; Chen CY
    Drug Des Devel Ther; 2016; 10():3281-3290. PubMed ID: 27757017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous urocortin II decreases blood pressure through CRF(2) receptor in rats.
    Chen CY; Doong ML; Rivier JE; Taché Y
    Regul Pept; 2003 May; 113(1-3):125-30. PubMed ID: 12686471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.